Dopamine Agonists: all 968 studies that test it
Page 7 of 10. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-upCompletedNCT02534363Phase 4
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-upStatus unknownNCT02532491Phase 4
- Early Vascular Adjustments During Hypertensive PregnancyStatus unknownNCT02531490Phase 4
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-upCompletedNCT02526030Phase 4
- A D1 Agonist For Working MemoryCompletedNCT02507206Phase 2
- Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy VolunteersCompletedNCT02501109Phase 1
- A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)CompletedNCT02486432Phase 1
- Bromocriptine and Insulin SensitivityCompletedNCT02428946Not applicable
- Dopaminergic Effects on Brown Adipose TissueCompletedNCT02428933Not applicable
- Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With SchizophreniaCompletedNCT02411695Phase 1
- Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered VaginallyStatus unknownNCT02410759Phase 3
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's DiseaseCompletedNCT02373072Phase 1
- L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's DiseaseStatus unknownNCT02347059Phase 2
- Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke RehabilitationWithdrawnNCT02346630Phase 4
- Pan European Collaboration on Antipsychotic Naïve Schizophrenia IICompletedNCT02339844Phase 4
- Infusion of Apomorphine: Long-term Safety StudyActive, not recruitingNCT02339064Phase 3
- Pharmacokinetic Study in Healthy MalesCompletedNCT02312232Phase 1
- Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered VaginallyStatus unknownNCT02306733Phase 3
- Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm InjectionStatus unknownNCT02306564Phase 2/3
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective PsychosisCompletedNCT02305823Phase 4
- Dopamine Agonist Treatment of Non-functioning Pituitary AdenomasActive, not recruitingNCT02288962Phase 3
- Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation SyndromeCompletedNCT02271360Phase 2/3
- To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related ParkinsonismCompletedNCT02265484Not applicable
- Increasing Dose Study of Pramipexole in Two-way Cross-over Comparison of ER Tablet Versus IR Tablet in Japanese Healthy Male VolunteersCompletedNCT02264132Phase 1
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy SubjectsCompletedNCT02262767Phase 1
- Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female VolunteersCompletedNCT02262546Phase 1
- Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male VolunteersCompletedNCT02261103Phase 1
- Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's DiseaseCompletedNCT02233023Phase 4
- Treatment of Apomorphine-induced Skin Reactions: a Pilot StudyTerminatedNCT02230930Phase 2
- Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and IrritabilityWithdrawnNCT02212613Phase 3
- A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed ConditionsCompletedNCT02184429Phase 1
- Pramipexole in Untreated and Levodopa-treated Parkinson's Disease PatientsCompletedNCT02177357Phase 3
- Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's DiseaseCompletedNCT02172573Phase 3
- European Long-acting Antipsychotics in Schizophrenia TrialCompletedNCT02146547Phase 4
- Antipsychotic to Treat Psychosis SyndromeStatus unknownNCT02137616Not applicable
- Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation SyndromeCompletedNCT02134249Phase 2/3
- Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot StudyStatus unknownNCT02133755Phase 3
- Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy SubjectsWithdrawnNCT02116790Phase 2
- Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of DiseaseTerminatedNCT02103465Phase 2
- Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic SyndromeStatus unknownNCT02101138Phase 2
- Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus SubjectsCompletedNCT02078440Phase 1
- Study to Evaluate the Efficacy and Safety of AripiprazoleStatus unknownNCT02069977Phase 4
- A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese VolunteersCompletedNCT02066909Phase 1
- Autonomic Function and Cardiovascular Risk in Restless Legs SyndromeCompletedNCT02025608Phase 4
- Adjunctive Aripiprazole in the Treatment of Risperidone-Induced HyperprolactinemiaStatus unknownNCT02013232Not applicable
- Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I DisorderWithdrawnNCT01981811Phase 2
- A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751CompletedNCT01981694Phase 1
- Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean SubjectsCompletedNCT01964573Phase 1
- A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older AdultsWithdrawnNCT01942187Phase 4
- Targeting Dopamine Therapy in RLSStatus unknownNCT01937169Not applicable
- Oral Antihypertensive Regimens for Management of Hypertension in PregnancyCompletedNCT01912677Phase 4
- Community Level Interventions for Pre-eclampsiaCompletedNCT01911494Not applicable
- Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune TreatmentTerminatedNCT01893450Not applicable
- Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to ProgressCompletedNCT01869556Not applicable
- Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian SubjectsCompletedNCT01854216Phase 1
- Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs SyndromeCompletedNCT01823770Phase 4
- Vaginal Bromocriptine for Treatment of AdenomyosisCompletedNCT01821001Phase 1
- An Study of Aripiprazole in the Treatment of Methamphetamine DependenceTerminatedNCT01813656Phase 4
- A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated PsychosisTerminatedNCT01813643Phase 4
- Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF EpisodesCompletedNCT01777555Phase 2
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective PsychosisStatus unknownNCT01765829Phase 3
- Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female SubjectsCompletedNCT01761526Phase 1
- Apomorphine Effects on Experimental PainCompletedNCT01744964Early Phase 1
- A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum DisordersStatus unknownNCT01742390Phase 4
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic SyndromeCompletedNCT01714011Phase 4
- Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg TabletsCompletedNCT01712568Phase 1
- Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders PatientsStatus unknownNCT01710163Phase 4
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive DisorderCompletedNCT01696617Phase 4
- Phase IIa Multicentre Study Investigating of VR040 in Parkinson's DiseaseCompletedNCT01693081Phase 2
- Fenoldopam for Prevention of Acute Kidney InjuryStatus unknownNCT01690832Phase 4
- Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's DiseaseCompletedNCT01683292Phase 2
- Remission of ICD by Switching Dopamine Agonist to Levodopa/CarbidopaCompletedNCT01683253Phase 4
- Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese SubjectsCompletedNCT01675024Phase 1
- Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild PreeclampsiaCompletedNCT01674127Phase 2
- Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's DiseaseCompletedNCT01673724Phase 4
- Canadian Biomarker Integration Network for Depression StudyCompletedNCT01655706Phase 3
- Pramipexole as a Treatment for Cocaine DependenceCompletedNCT01651377Phase 1
- A Pilot Study of Cabergoline for the Treatment of Cocaine DependenceCompletedNCT01651364Phase 1
- Antipsychotic Augmentation With L-DopaCompletedNCT01636037Phase 2
- Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed ConditionCompletedNCT01627847Phase 1
- Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting ConditionCompletedNCT01627834Phase 1
- Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" EpisodesCompletedNCT01617135Phase 2
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five AntipsychoticsCompletedNCT01607762Phase 1
- Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food EffectsCompletedNCT01607034Phase 1
- Dexpramipexole and Warfarin Drug Drug Interaction (DDI) StudyCompletedNCT01597310Phase 1
- Ovarian Hyperstimulation Syndrome and CabergolineCompletedNCT01569256Not applicable
- Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese SubjectsCompletedNCT01565018Phase 1
- Change in Brain Metabolism and Cognitive Function by AripiprazoleCompletedNCT01562808Not applicable
- Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)CompletedNCT01536249Phase 1
- Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS BiomarkersCompletedNCT01535859Phase 3
- Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot StudyTerminatedNCT01520350Phase 3
- Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)Status unknownNCT01515774Phase 4
- Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)CompletedNCT01511029Phase 1
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive DisorderStatus unknownNCT01488266Not applicable
- A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's DiseaseCompletedNCT01484990Phase 1
- Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality DisorderStatus unknownNCT01466205Phase 2
- Cabergoline Effect on Blood Sugar in Type 2 DiabeticsStatus unknownNCT01459601Not applicable
- Dexpramipexole SAD/MAD StudyCompletedNCT01449578Phase 1
- Bergen Psychosis Project 2 - The Best Intro StudyCompletedNCT01446328Phase 4